{"nct_id":"NCT01831726","title":"Dovitinib for Patients With Tumor Pathway Activations Inhibited by Dovitinib","status":"COMPLETED","status_verified_date":"2017-01","start_date":"2013-08","start_date_type":null,"primary_completion_date":"2015-12","primary_completion_date_type":"ACTUAL","completion_date":"2015-12","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["NVS"]}